- Filed
- May 2, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Apr 25, 2025 | 55.23M sh |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $3.62B |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $3.12B |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $3.96B |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $3.21B |
| Current Assets | Q3 2025 · Mar 31, 2025 | $4.1B |
| Current Assets | Q3 2025 · Jun 30, 2024 | $3.52B |
| Total Assets | Q3 2025 · Mar 31, 2025 | $5.17B |
| Total Assets | Q3 2025 · Jun 30, 2024 | $4.25B |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $401.81M |
| Cash And Equivalents | Q3 2025 · Mar 31, 2024 | $492.7M |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 57.05M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 56.98M sh |
| Stock Repurchased | Q3 2025 · Mar 31, 2024 | $0 |
| Capex | Q3 2025 · Mar 31, 2024 | $11.7M |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | $304.74M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $1.1B |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $986.77M |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | $842.86M |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $1.50 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $2.77 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $1.51 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $2.81 |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $48.86M |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $142.13M |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $43.39M |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $134.13M |
| Net Income | Q3 2025 · Mar 31, 2024 | $85.31M |
| Net Income | Q3 2025 · Mar 31, 2024 | $157.95M |
| Operating Income | Q3 2025 · Mar 31, 2024 | $106.29M |
| Operating Income | Q3 2025 · Mar 31, 2024 | $197.18M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $285.3M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $720.38M |
| Revenue | Q3 2025 · Mar 31, 2024 | $366.84M |
| Revenue | Q3 2025 · Mar 31, 2024 | $956.94M |